FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

ALEMBICLTD

85.3
+6.1 (7.7%)
Updated 03:29 03/08 IST

ALEMBICLTD Buy or Sell - FrontPage Forums

0 Users have submitted 0 trade ideas of Rs. 0 for ALEMBICLTD
Disclaimer
0% Bullish
0% Bearish

ALEMBICLTD Buy or Sell - Brokerage Reports

No. of reports in last year
0
No. of analysts
0
Average Consensus Forecast
Consensus Potential
0.00%
See ALEMBICLTD Share Price Targets >>

ALEMBICLTD Ratings

Long term ALEMBICLTD rating by FrontPage users
0/5 (0 Ratings)0
Find answers to all your questions on live ALEMBICLTD message board: Is ALEMBICLTD buy or sell? Should I buy ALEMBICLTD shares? Why are ALEMBICLTD shares falling? Should I invest in ALEMBICLTD stock?

  1. Home
  2. ALEMBICLTD Forum

ALEMBICLTD Share Price Discussion

M
Reputation: -6,202 • Today 8:14 AM

Type
Buy
Instrument
ALEMBICLTD
Entry Price
₹84.5
Price@Trade
₹84.75
Target Price
₹95
Stop Price
₹79.5
Valid Till
Aug 10, 2020 3:20 AM
Margin
₹84,500 approx for 1000 Qty
Status
Waiting for entry
Like
Reply
N
Reputation: 4,625 • Jul 28 7:43 AM
Market up 48% from March lows; time to change strategy and rejig portfolio?
The recent rally has brought many stocks near their peak valuation, Investors can relook at their portfolio and bring down the equity portion if it has exceeded the intended allocation, say experts.
Moneycontrol
Like
Reply
T
Reputation: 15,860 • Jul 16 2:21 AM
Like
Reply
Like
Reply
S
Reputation: 762 • Jul 3 3:43 AM

Type
Buy
Instrument
ALEMBICLTD
Entry Price
₹83.3
Price@Trade
₹83.85
Target Price
₹87.5
Stop Price
₹81.95
Valid Till
Jul 3, 2020 3:20 AM
Margin
₹83,300 approx for 1000 Qty
Status
Stoploss Hit
Exit Price
₹81.95
Net P&L
-₹1,350 (-1.62%)
BUY ALUMBIC ABOVE 83.25 TARGET85.3-87.5 STOPLOSS 81.95
Like
Reply (2)
Latest replies
TrackerBot @trackerbot
Jul 3 3:46 AM

Update
Trade Entered
Entry Price
₹83.3
TrackerBot @trackerbot
Jul 3 4:18 AM

Update
Stoploss Hit
Exit Price
₹81.95
S
Reputation: 762 • Jul 3 3:42 AM
SAGAANI in ALEMBICLTD
#ALEMBICLTD BUY ALUMBIC ABOVE 83.25 TARGET85....
Like
Reply
S
Reputation: 762 • Jul 3 3:42 AM


BUY ALUMBIC ABOVE 83.25 TARGET85.3-87.5 STOPLOSS 81.95
Like
Reply
S
Reputation: 762 • Jun 22 2:41 AM


buy alumbic ltd above 81 target 83-85.2-87.5 stoploss 79.45
Like
Reply
N
Reputation: 4,625 • Jun 19 3:23 AM
Amrutanjan Heal Standalone March 2020 Net Sales at Rs 59.29 crore, down 31.03% Y-o-Y
Moneycontrol
Like
Reply
N
Reputation: 4,625 • Jun 5 2:58 AM
Hedge fund Sylebra acquires 1.1% stake in PVR, promoter Nirayu buys 1.5% in Alembic
Total promoter and promoter group shareholding in Alembic stood at 67.62 percent, including Nirayu's 59.80 percent as of March 31
Moneycontrol
1
Reply
1
Reply
P
Reputation: 334 • Jan 28 4:37 AM

Alembic Pharmaceuticals (Alembic) on Tuesday (28 January) announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Azithromycin tablets USP, 600 mg. The approved ANDA is therapeutically equivalent...
Read more...
Like
Reply

Alembic reports Q3 FY20 results during market hours. PAT grew 38% y/y to Rs 234.2 crore. Revenue increased 18.8% y/y to Rs 1,209 crore. Margin also expanded 310bps y/y to 26.9%. The stock closed 1.5% lower.
1
Reply

Alembic Pharmaceuticals received tentative approval from the U.S. FDA for its abbreviated new drug application (ANDA) Empagliflozin Tablets, 10 mg and 25 mg. The stock was up 0.7%.
Like
Reply
S
Reputation: 9,165 • Jan 15 3:28 AM

Alembic Pharma gets US FDA nod for muscle relaxant drug Tizanidine Hydrochloride
Like
Reply

BRIEF-India's Alembic Receives USFDA Approvals For Deferasirox Tablets - Reuters
22-Nov-2019 12:48:46 PM
Nov 22 (Reuters) - Alembic Pharmaceuticals Ltd ALEM.NS:
RECEIVES USFDA APPROVALS
RECEIVES FINAL USFDA APPROVALS FOR DEFERASIROX TABLETS 90, 360 MG AND DEFERASIROX TABLETS FOR ...
Read more...
2
Reply

Alembic Receives USFDA Approvals For Deferasirox Tablets
Like
Reply
B
Reputation: 745 • Nov 6, 2019 2:13 AM

ALEMBICLTD - chart - 426479
Alembic Pharma Witnessing Good Delivery Volumes. Monthly Chart Bullish Flag Breakout.
#nifty #banknifty #trading #equityderivatives #nism #StockMarket
Like
Reply
N
Reputation: 4,625 • May 23, 2019 10:53 AM
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • ALEMBICLTD - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization1,084.98
    Enterprise Value1,082.99
    Price to Earnings34.72
    Price to Book Value2.6
    Return on Capital Employed0.12
    Return on Equity0.12
    Face Value2
    Dividend YieldNA
  • ALEMBICLTD Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Aug 379.0585.6579.0584.7
    Jul 3179.658178.479.2
    Jul 3077.581.8577.578.95
    Jul 2977.279.257777.5
    Jul 2877.3578.8576.5577.65
  • ALEMBICLTD Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹81.59
    30 Day Moving Average₹80.7
    50 Day Moving Average₹72.79
    100 Day Moving Average₹59.04
    200 Day Moving Average₹56.03
  • ALEMBICLTD - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue125144.26-0.13
    Operating Profit110.9111.09
    Profit Before Tax4426.630.65
    Net Income4127.490.49
  • ALEMBICLTD - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds4183460.21
    Total Liabilities58181-0.68
    Total Assets476528-0.1
  • ALEMBICLTD - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity2351.63-0.55
    Cash from Investing Activity-22-46.69-0.53
    Cash from Financing Activity-2-4.96-0.6
    Net Cash Flow-1-0.0249
  • ALEMBICLTD - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.080.06
    Return on Equity0.120.07
    Return on Capital Employed0.120.07
  • ALEMBICLTD - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue-0.13
    3 Year CAGR Growth in Operating Profit0.11
    3 Year CAGR Growth in EBIDTA0.52
    3 Year CAGR Growth in Net Income0.7
    3 Yr CAGR Growth - Diluted EPS0.71
  • ALEMBICLTD - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue-0.3
    5 Year CAGR Growth in Operating Profit-0.3
    5 Year CAGR Growth in EBIDTA0.77
    5 Year CAGR Growth in Net Income2.57
    3 Yr CAGR Growth - Diluted EPS0.79
  • ALEMBICLTD - Recent News

    keyboard_arrow_down
    NewsBot
    Jun 19 3:23 AM
    Amrutanjan Heal Standalone March 2020 Net Sales at Rs 59.29 crore, down 31.03% Y-o-Y
    Moneycontrol
    NewsBot
    Jun 5 2:58 AM
    Hedge fund Sylebra acquires 1.1% stake in PVR, promoter Nirayu buys 1.5% in Alembic
    Moneycontrol
    NewsBot
    May 23, 2019 10:53 AM
    NewsBot
    Feb 12, 2019 11:57 AM
  • ALEMBICLTD - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Apollo Hospitals Enterprise Ltd. NSE:...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020